Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KLF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARD6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC28A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHDC7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929072 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MED12L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYSND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129455 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130987 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724200 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNA21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATXN7L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on